Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 15 images provide visual information about the product associated with Pregabalin NDC 71610-677 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 75 mg - 71610 0677 30
Aphena Pharma Solutions - TN - Aphena
Figure 1 - pregabalin fig01
Figure 2 - pregabalin fig02
This appears to be a chart showing the percent improvement in pain from a baseline for patients taking Pregabalin 160 mg for three days. The chart includes some numerical values for improvement and time frames but is incomplete and difficult to interpret without additional context.*
Figure 3 - pregabalin fig03
This appears to be a chart showing the percentage of patients who reported improvement in pain from baseline after taking different medications including Pregatalin 300, Pregabain 160, and Pregabalin 75. However, the formatting is not clear and there are some unreadable characters.*
Figure 4 - pregabalin fig04
Figure 5 - pregabalin fig05
The text seems to represent the result of a clinical trial for pain management, comparing two medications and a placebo. However, due to a high number of errors and lack of context, it is difficult to provide a detailed description of the trial and its outcomes.*
Figure 6 - pregabalin fig06
Figure 7 - pregabalin fig07
Figure 9 - pregabalin fig08
This is a chart showing the percentage of patients who experienced improvement in pain from their baseline using either a daily dose of Pregabalin 300mg or 450mg and a placebo. The results are shown on a scale from 0 to 100, along with corresponding levels of percent improvement in pain.*
Figure 10 - pregabalin fig09
This data shows the estimated percentage of subjects without LTR (loss to follow-up) over a 120-day period. The study includes two groups: one receiving "Progabain" and one receiving "Placebo". The percentages range from 0% to 100% with increments of 10%. The X-axis represents the number of days in the study (ranging from day 0 to day 120).*
Figure 11 - pregabalin fig10
Figure 12 - pregabalin fig11
The data represents the percentage of subjects who showed improvement after taking Pregabalin and Placebo for 16 weeks. The percentage of improvement is shown on the vertical axis and ranges from 0 to 100. The horizontal axis shows the values 210 through 270 in increments of 10. The improvement of Pregabalin is represented by the blue line while the improvement of Placebo is represented by the orange line. The graph is a bar chart and shows that Pregabalin resulted in a higher percentage of improvement than Placebo.*
Cockcroft and Gault equation - pregabalin formula
This text appears to be a medical formula for calculating the CLCT (Creatinine clearance test) using age, weight, and serum creatinine levels. However, some characters are not readable, rendering the formula incomplete and difficult to interpret accurately.*
Chemical Structure - pregabalin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.